Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
Understanding US disparities in HCC survival by etiology can help guide the identification of etiologically specific biomarkers and potential therapeutic targets and inform public health measures.
Authors
- Robert J. Wong (ORCID: https://orcid.org/0000-0002-8923-2806)
- Patricia D. Jones (ORCID: https://orcid.org/0000-0003-4189-6731)
- Paulo S. Pinheiro (ORCID: https://orcid.org/0000-0001-8502-835X)
- Hannah M. Cranford (ORCID: https://orcid.org/0000-0002-9502-2864)
- Tulay Koru‐Sengul (ORCID: https://orcid.org/0000-0003-0974-8405)
- Isildinha M. Reis (ORCID: https://orcid.org/0000-0002-7695-8771)
- Qinran Liu (ORCID: https://orcid.org/0000-0001-7090-8485)
- Erin N. Kobetz (ORCID: https://orcid.org/0000-0001-9215-5525)
Institutions
- University of Miami (US)
- Palo Alto University (US)
- VA Palo Alto Health Care System (US)
- University of Miami Health System (US)
- Stanford University (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1158/1055-9965.epi-24-0626
- Citations
- 12
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.64
Funders
- Gilead Sciences
- University of Miami
- Florida Department of Health
- Sylvester Comprehensive Cancer Center, University of Miami Health Systems
- National Institutes of Health
- Leonard M. Miller School of Medicine